What Researchers Did
Researchers conducted a narrative review to discuss past experiences and considerations in designing sham hyperbaric treatments for double-blind trials.
What They Found
They identified 42 eligible sham-controlled trials on hyperbaric oxygen therapy by searching MEDLINE, Embase, and CENTRAL. The review focused on the choice of treatment profile, blinding measures, patient perception of allocation, and safety issues in these trials.
What This Means for Canadian Patients
This review highlights the importance of well-designed sham controls in hyperbaric oxygen therapy trials, which can lead to more robust evidence for treatment efficacy. Ultimately, this could help ensure that Canadian patients receive treatments supported by high-quality research.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
As a narrative review, this study may be limited by its subjective interpretation of the literature rather than a systematic quantitative analysis.